Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
about
MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.
P2860
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@en
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@nl
type
label
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@en
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@nl
prefLabel
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@en
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@nl
P2093
P2860
P356
P1433
P1476
Effects of Jak2 type 1 inhibit ...... d Bcr-Abl-positive cell lines.
@en
P2093
Bernd Dörken
Christian Oberender
Fanny Marque
Frauke Ringel
Jaspal Kaeda
Michaela Schwarz
Paul W Manley
Peggy Grille
Philipp le Coutre
Thomas Radimerski
P2860
P356
10.1159/000356784
P577
2014-01-31T00:00:00Z